Montana Statutes
§ 50-32-201 — General Criteria To Be Considered
Montana·Title 50 HEALTH AND SAFETY·Ch. 32 CONTROLLED SUBSTANCES·Part 2 Scheduling of Dangerous Drugs
50-32-201 . General criteria to be considered. In making a determination regarding a drug, the board shall consider the following:
(1)the actual or relative potential for abuse;
(2)the scientific evidence of its pharmacological effect, if known;
(3)the state of current scientific knowledge regarding the drug;
(4)the history and current pattern of abuse;
(5)the scope, duration, and significance of abuse;
(6)the risk to the public health;
(7)the potential of the drug to produce psychic or physiological dependence liability; and
(8)whether the drug is an immediate precursor of a drug already controlled under this chapter.
Free access — add to your briefcase to read the full text and ask questions with AI
Montana § 50-32-201 (General Criteria To Be Considered) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
En. Sec. 2, Ch. 412, L. 1973; amd. Sec. 2, Ch. 350, L. 1974; R.C.M. 1947, 54-302(part).
Nearby Sections
15
§ 50-32-101
Definitions§ 50-32-102
Uniformity Of Construction§ 50-32-103
Board To Administer Chapter§ 50-32-104
Board's Authority Limited§ 50-32-105
Board To Conduct Educational Programs§ 50-32-106
Board To Encourage Research§ 50-32-201
General Criteria To Be Considered§ 50-32-202
Designation Of Drug As Dangerous Drug§ 50-32-203
Effect Of Rescheduling Under Federal Law§ 50-32-204
Immediate Precursors§ 50-32-205
Nonprescription Drugs Not To Be Scheduled§ 50-32-206
Use Of Names Of Scheduled Drugs§ 50-32-207
Order Forms For Drugs In Schedules I And Ii§ 50-32-209
Republication Of Schedules